MapLight Therapeutics, Inc. (MPLT)
11.85
+0.49
(+4.31%)
USD |
NASDAQ |
Aug 25, 11:55
MapLight Therapeutics Price to Book Value : 1.546 for Aug. 25, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 1.482 |
| August 21, 2026 | 1.462 |
| August 20, 2026 | 1.465 |
| August 19, 2026 | 1.585 |
| August 18, 2026 | 1.542 |
| August 17, 2026 | 1.467 |
| August 14, 2026 | 1.533 |
| August 13, 2026 | 1.511 |
| August 12, 2026 | 1.485 |
| August 11, 2026 | 1.563 |
| August 10, 2026 | 1.589 |
| August 07, 2026 | 1.588 |
| August 06, 2026 | 1.732 |
| August 05, 2026 | 1.686 |
| August 04, 2026 | 1.688 |
| August 03, 2026 | 1.637 |
| July 31, 2026 | 1.698 |
| July 30, 2026 | 1.830 |
| July 29, 2026 | 1.959 |
| July 28, 2026 | 1.606 |
| July 27, 2026 | 1.292 |
| July 24, 2026 | 4.769 |
| July 23, 2026 | 4.596 |
| July 22, 2026 | 4.606 |
| July 21, 2026 | 4.884 |
| Date | Value |
|---|---|
| July 20, 2026 | 4.695 |
| July 17, 2026 | 4.940 |
| July 16, 2026 | 4.856 |
| July 15, 2026 | 4.870 |
| July 14, 2026 | 4.946 |
| July 13, 2026 | 4.771 |
| July 10, 2026 | 5.129 |
| July 09, 2026 | 5.192 |
| July 08, 2026 | 5.026 |
| July 07, 2026 | 4.835 |
| July 06, 2026 | 4.571 |
| July 02, 2026 | 4.838 |
| July 01, 2026 | 4.707 |
| June 30, 2026 | 4.676 |
| June 29, 2026 | 3.878 |
| June 26, 2026 | 3.763 |
| June 25, 2026 | 3.614 |
| June 24, 2026 | 3.466 |
| June 23, 2026 | 3.238 |
| June 22, 2026 | 3.368 |
| June 18, 2026 | 3.259 |
| June 17, 2026 | 3.303 |
| June 16, 2026 | 3.071 |
| June 15, 2026 | 3.161 |
| June 12, 2026 | 3.138 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Evommune, Inc. | 1.857 |
| Sarepta Therapeutics, Inc. | 1.303 |
| Cullinan Therapeutics, Inc. | 4.584 |
| Mineralys Therapeutics, Inc. | 4.232 |
| Apogee Therapeutics, Inc. | 8.504 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0163 |
| Price | 11.85 |
| Earnings Yield | -43.23% |
| Market Cap | 538.43M |
| PEGY Ratio | -0.0163 |